Breaking News, Collaborations & Alliances

Gilead Bolsters Biologics Capabilities

Licenses ProteoNic’s 2G UNic Technology Platform for production of biologics.

By: Contract Pharma

Contract Pharma Staff

ProteoNic, a provider of technology and services for efficient production of biologics, has licensed its premium 2G UNic technology for boosting therapeutic protein production to Gilead Sciences. Gilead gains non-exclusive commercial rights for application of ProteoNic’s technology platform to the development of its proprietary products from mammalian cells. Financial details of the agreement were not disclosed.   ProteoNic’s protein expression technology improves production levels a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters